Zevra Therapeutics, Inc. (ZVRA)
(Real Time Quote from BATS)
$6.46 USD
+0.23 (3.69%)
Updated Jul 16, 2024 02:20 PM ET
4-Sell of 5 4
F Value F Growth F Momentum F VGM
Cash flow Statements
Fiscal Year End for Zevra Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -46.05 | -41.54 | -8.56 | -12.76 | -24.52 |
Depreciation/Amortization & Depletion | 1.01 | 0.94 | 0.41 | 2.58 | 1.96 |
Net Change from Assets/Liabilities | 5.88 | -0.47 | -0.36 | 0.37 | -5.12 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 5.63 | 22.35 | 18.94 | 7.87 | 3.95 |
Net Cash From Operating Activities | -33.54 | -18.72 | 10.44 | -1.94 | -23.74 |
Property & Equipment | -0.30 | -0.09 | -0.10 | -0.03 | -0.03 |
Acquisition/ Disposition of Subsidiaries | -30.40 | -14.09 | 0.00 | 0.00 | 0.00 |
Investments | 13.31 | -22.54 | -15.42 | 0.00 | 3.26 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -17.39 | -36.72 | -15.52 | -0.03 | 3.23 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 2.88 | -4.40 | 77.29 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | 25.59 | 12.75 | 40.03 | 0.55 | -0.21 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 2.30 | 5.45 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | -4.22 | -0.12 | -0.30 |
Net Cash from Financing Activities | 28.46 | 8.35 | 113.11 | 2.74 | 4.94 |
Effect of Exchange Rate Changes | 0.04 | 0.20 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -22.42 | -46.88 | 108.02 | 0.77 | -15.56 |
Cash at Beginning of Period | 65.47 | 112.35 | 4.32 | 3.56 | 19.12 |
Cash at End of Period | 43.05 | 65.47 | 112.35 | 4.32 | 3.56 |
Diluted Net EPS | -1.30 | -1.20 | -2.11 | -3.21 | -13.28 |
Fiscal Year End for Zevra Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -16.62 | -46.05 | -30.90 | -16.85 |
Depreciation/Amortization & Depletion | NA | 1.56 | 1.01 | 0.22 | 0.16 |
Net Change from Assets/Liabilities | NA | -0.15 | 5.88 | 9.00 | 1.25 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | -0.96 | 5.63 | 4.30 | 2.70 |
Net Cash From Operating Activities | NA | -16.17 | -33.54 | -17.38 | -12.75 |
Property & Equipment | NA | 0.00 | -0.30 | -0.22 | -0.05 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | -30.40 | 0.00 | 0.00 |
Investments | NA | 14.79 | 13.31 | -27.75 | 16.53 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | 14.79 | -17.39 | -27.98 | 16.48 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 1.22 | 2.88 | -3.23 | -3.28 |
Issuance (Repayment) of Debt | NA | 0.00 | 25.59 | 26.69 | 0.48 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 1.22 | 28.46 | 23.46 | -2.80 |
Effect of Exchange Rate Changes | NA | -0.05 | 0.04 | -0.31 | -0.20 |
Net Change In Cash & Equivalents | NA | -0.20 | -22.42 | -22.20 | 0.73 |
Cash at Beginning of Period | NA | 43.05 | 65.47 | 65.47 | 65.47 |
Cash at End of Period | NA | 42.85 | 43.05 | 43.27 | 66.20 |
Diluted Net EPS | NA | -0.40 | -0.41 | -0.40 | -0.15 |